Trade Summary

3 days ago, Edwards Larry Todd, serving as See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,687 shares at $25.18 per share, for a total transaction value of $92,846.00. Following this transaction, Edwards Larry Todd now holds 175,178 shares of ARQT.

This sale represents a 2.00% decrease in Edwards Larry Todd's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 3, 2026, 1 day after the trade was made.

Arcutis Biotherapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.